Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 301 – 320 of 3236

Doxorubicin Hydrochloride (Liposomal)

https://clinicalinfo.hiv.gov/drugs/doxorubicin-hydrochloride-liposomal/fda-label

https://clinicalinfo.hiv.gov/drugs/rituximab/patient

https://clinicalinfo.hiv.gov/drugs/rituximab/patient

https://clinicalinfo.hiv.gov/drugs/rituximab/fda-label

Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

https://clinicalinfo.hiv.gov/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-7

Actualizaciones a las Guías para la Prevención y Tratamiento de Infecciones oportunistas en adultos y adolescentes con VIH

https://clinicalinfo.hiv.gov/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-7

https://clinicalinfo.hiv.gov/drugs/podofilox/patient

https://clinicalinfo.hiv.gov/drugs/podofilox/patient

https://clinicalinfo.hiv.gov/drugs/podofilox/fda-label

National HIV Testing Day

https://clinicalinfo.hiv.gov/news/national-hiv-testing-day

Día Nacional de la Prueba del VIH

https://clinicalinfo.hiv.gov/news/national-hiv-testing-day

https://clinicalinfo.hiv.gov/drugs/rifapentine/patient

https://clinicalinfo.hiv.gov/drugs/rifapentine/patient

https://clinicalinfo.hiv.gov/drugs/rifapentine/fda-label

Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

https://clinicalinfo.hiv.gov/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-8

Actualizaciones a las Guías para la Prevención y Tratamiento de Infecciones Oportunistas en Adultos y Adolescentes con VIH

https://clinicalinfo.hiv.gov/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-8

Penicillin G Benzathine

https://clinicalinfo.hiv.gov/drugs/penicillin-g-benzathine/patient

Penicilina G benzatínica

https://clinicalinfo.hiv.gov/drugs/penicillin-g-benzathine/patient

Penicillin G Benzathine

https://clinicalinfo.hiv.gov/drugs/penicillin-g-benzathine/fda-label

https://clinicalinfo.hiv.gov/drugs/lotivibart/health-professional